Canada Gazette, Part I, Volume 156, Number 40: GOVERNMENT NOTICES

October 1, 2022

BANK OF CANADA

Statement of financial position as at August 31, 2022 (unaudited)

Amounts are in millions of dollars.

Totals

Assets and Liabilities and Equity
Item Amount
Assets 439,151
Liabilities and Equity 439,151

Assets

Cash and foreign deposits
Item Amount
Cash and foreign deposits 10
Loans and receivables
Item Amount
Securities purchased under resale agreements 427
Advances to members of Payments Canada n/a
Other receivables 7
Total loans and receivables 434
Investments
Item Amount
Government of Canada treasury bills n/a
Government of Canada bonds — carried at amortized cost 117,397
Government of Canada bonds — carried at fair value through profit and loss 246,246
Canada Mortgage Bonds 9,194
Other bonds 10,595
Securities lent or sold under repurchase agreements 22,915
Other securities n/a
Shares in the Bank for International Settlements (BIS) 460
Total investments 406,807
Derivatives — Indemnity agreements with the Government of Canada
Item Amount
Derivatives — Indemnity agreements with the Government of Canada 30,786
Capital assets
Item Amount
Property and equipment 517
Intangible assets 106
Right-of-use leased assets 46
Total capital assets 669
Other assets
Item Amount
Other assets 445

Liabilities and Equity

Bank notes in circulation
Item Amount
Bank notes in circulation 116,620
Deposits
Item Amount
Government of Canada 95,815
Members of Payments Canada 191,779
Other deposits 11,725
Total deposits 299,319
Securities sold under repurchase agreements
Item Amount
Securities sold under repurchase agreements 21,487
Other liabilities
Item Amount
Other liabilities 764
Total liabilities
Item Amount
Total liabilities 438,190
Equity
Item Amount
Share capital 5
Statutory and special reserves 125
Investment revaluation reserve 421
Actuarial gains reserve 411
Total equity 962

I declare that the foregoing statement is correct according to the books of the Bank.

Ottawa, September 20, 2022

Coralia Bulhoes
Chief Financial Officer and Chief Accountant

I declare that the foregoing statement is to the best of my knowledge and belief correct, and shows truly and clearly the financial position of the Bank, as required by section 29 of the Bank of Canada Act.

Ottawa, September 20, 2022

Tiff Macklem
Governor

DEPARTMENT OF THE ENVIRONMENT DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication of final decision after screening assessment of four substances of the Protein Derivatives and Yeast Extract Group specified on the Domestic Substances List (paragraphs 68(b) and (c) or subsection 77(6) of the Canadian Environmental Protection Act, 1999)

Whereas yeast extract and isostearoyl hydrolyzed collagen identified in the annex below are substances identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a summary of the screening assessment conducted on protein hydrolyzates and collagen hydrolyzates pursuant to paragraphs 68(b) and (c) of the Act and on yeast extract and isostearoyl hydrolyzed collagen pursuant to section 74 of the Act is annexed hereby;

And whereas it is concluded that the substances do not meet any of the criteria set out in section 64 of the Act,

Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action at this time under section 77 of the Act for the two substances identified under subsection 73(1) of the Act.

Notice is further given that the ministers propose to take no further action on the remaining two substances at this time.

Steven Guilbeault
Minister of the Environment

Jean-Yves Duclos
Minister of Health

ANNEX

Summary of the screening assessment of the Protein Derivatives and Yeast Extract Group

Pursuant to section 68 or 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted a screening assessment of four substances referred to collectively as the Protein Derivatives and Yeast Extract Group. The Chemical Abstracts Service Registry Numbers (CAS RNs),footnote 1 the Domestic Substances List (DSL) names and the common names of these substances are listed in the table below.

Substances in the Protein Derivatives and Yeast Extract Group
CAS RN DSL name Common name
8013-01-2 table 14 note a Yeast, ext. Yeast extract
9015-54-7 table 14 note a table 14 note b Protein hydrolyzates N/A
92113-31-0 table 14 note a table 14 note b Collagens, hydrolyzates Collagen hydrolyzates
111174-63-1 table 14 note a Protein hydrolyzates, leather, reaction products with isostearoyl chloride Isostearoyl hydrolyzed collagen

Table 14 note(s)

Table 14 note a

The substance bearing this CAS RN is a UVCB (substance of unknown or variable composition, complex reaction product, or biological material).

Return to table 14 note a referrer

Table 14 note b

This substance was not identified under subsection 73(1) of CEPA but was included in this assessment as it was considered a priority through other mechanisms.

Return to table 14 note b referrer

Abbreviations: N/A, not available

The substances in the Protein Derivatives and Yeast Extract Group are derived from naturally occurring biological materials. The composition of the yeast extract, protein hydrolyzates, collagen hydrolyzates, and isostearoyl hydrolyzed collagen varies depending on the source of the material and manufacturing conditions. Data on all four substances were obtained in response to a CEPA section 71 survey. Between 100 000 kg and 1 000 000 kg of yeast extract, between 10 000 kg and 100 000 kg of protein hydrolyzates, and 67 702 kg of collagen hydrolyzates were imported to Canada for the reporting year of 2011. For the same year, no import volumes were reported for isostearoyl hydrolyzed collagen and no manufacture volumes were reported for any of the substances in the group in Canada above the reporting threshold of 100 kg. Reported uses include building or construction materials, food and beverage, nutritional product for animal feed, and personal care. More specifically, in Canada, substances in this group may be used in food as flavouring agents, for nutritional purposes in products such as protein supplements and infant formula, and in a number of products available to consumers, including cosmetics and natural health products. In addition, collagen hydrolyzates and yeast extract are formulants in pest control products.

The ecological risks of the substances in the Protein Derivatives and Yeast Extract Group were characterized using the ecological risk classification of organic substances (ERC), which is a risk-based approach that employs multiple metrics for both hazard and exposure, with weighted consideration of multiple lines of evidence for determining risk classification. Hazard profiles are based principally on metrics regarding mode of toxic action, chemical reactivity, food web–derived internal toxicity thresholds, bioavailability, and chemical and biological activity. Metrics considered in the exposure profiles include potential emission rate, overall persistence, and long-range transport potential. A risk matrix is used to assign a low, moderate or high level of potential concern for substances on the basis of their hazard and exposure profiles. Based on the outcome of the ERC analysis, substances in the Protein Derivatives and Yeast Extract Group are considered unlikely to be causing ecological harm.

Considering all available lines of evidence presented in this screening assessment, there is a low risk of harm to the environment from the four substances in the Protein Derivatives and Yeast Extract Group. It is concluded that yeast extract, protein hydrolyzates, collagen hydrolyzates and isostearoyl hydrolyzed collagen do not meet the criteria under paragraph 64(a) or (b) of CEPA as they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity or that constitute or may constitute a danger to the environment on which life depends.

With respect to human health, the hazard profiles of a variety of protein hydrolyzates of both plant and animal origin, which are representative of the substance protein hydrolyzates in the Protein Derivatives and Yeast Extract Group, show that no adverse effects have been observed in laboratory studies at doses up to the limit dose of 1 000 mg/kg bw/day. Similarly, for yeast extract and collagen hydrolyzates, there were no adverse effects reported in several laboratory studies. For isostearoyl hydrolyzed collagen, based on information on its individual reaction components isostearic acid and collagen hydrolyzates, and on other structurally similar amino acid alkyl amides, this substance is not expected to be associated with adverse health effects. Therefore, in consideration of the available toxicological information on a representative set of protein hydrolyzates (including those derived from yeast and collagen) and substances related to isostearoyl hydrolyzed collagen, the substances in the Protein Derivatives and Yeast Extract Group are considered to be of low hazard potential and therefore the risk to human health is considered to be low.

Considering all the information presented in this screening assessment, it is concluded that yeast extract, protein hydrolyzates, collagen hydrolyzates and isostearoyl hydrolyzed collagen do not meet the criteria under paragraph 64(c) of CEPA, as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.

Overall conclusion

It is therefore concluded that yeast extract, protein hydrolyzates, collagen hydrolyzates and isostearoyl hydrolyzed collagen do not meet any of the criteria set out in section 64 of CEPA.

The screening assessment for these substances is available on the Canada.ca (Chemical substances) website.

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Revocation of designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Vancouver Police Service as fingerprint examiners:

Ottawa, September 14, 2022

Julie Thompson
Director General
Crime Prevention Branch

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council appointments website.

Governor in Council appointment opportunities
Position Organization Closing date
Director Bank of Canada  
Director Business Development Bank of Canada  
Chairperson Canada Agricultural Review Tribunal  
Director Canada Development Investment Corporation  
Director Canada Foundation for Sustainable Development Technology  
Chairperson Canada Lands Company Limited  
President Canada Lands Company Limited  
Director Canada Post Corporation  
Member Canada–Nova Scotia Offshore Petroleum Board  
Chairperson Canadian Air Transport Security Authority  
Director Canadian Commercial Corporation  
Member Canadian Cultural Property Export Review Board  
Chairperson Canadian High Arctic Research Station  
Member Canadian High Arctic Research Station  
Vice-Chairperson Canadian High Arctic Research Station  
Chief Commissioner Canadian Human Rights Commission  
Member Canadian Human Rights Commission  
Member Canadian Human Rights Tribunal  
Secretary Canadian Intergovernmental Conference Secretariat  
Trustee Canadian Museum for Human Rights  
Director Canadian Museum of History  
Chairperson Canadian Museum of Nature  
Chairperson Canadian Radio-television and Telecommunications Commission  
Vice-Chairperson Canadian Radio-television and Telecommunications Commission  
Member Canadian Transportation Agency  
Special Representative on Combatting Islamophobia Department of Canadian Heritage  
Chairperson Export Development Canada  
Director Export Development Canada  
President Farm Credit Canada  
Director First Nations Financial Management Board  
Member Historic Sites and Monuments Board of Canada  
Commissioner International Commission on the Conservation of Atlantic Tunas  
Chairperson Invest in Canada Hub  
Chief Executive Officer Invest in Canada Hub  
Director Invest in Canada Hub  
Commissioner Law Commission of Canada  
President Law Commission of Canada  
Chairperson National Arts Centre Corporation  
Chairperson National Capital Commission  
Member National Capital Commission  
Member National Farm Products Council  
Vice-Chairperson National Farm Products Council  
Government Film Commissioner National Film Board  
Trustee National Museum of Science and Technology  
Member Net-Zero Advisory Body  
Canadian Representative North Atlantic Salmon Conservation Organization  
Canadian Representative North Pacific Anadromous Fish Commission  
Federal Ombudsman for Victims of Crime Office of the Federal Ombudsman for Victims of Crime  
Member Pacific Pilotage Authority  
Chairperson Patented Medicine Prices Review Board  
Member Payments in Lieu of Taxes Dispute Advisory Panel  
Chairperson Royal Canadian Mounted Police Management Advisory Board  
Member Royal Canadian Mounted Police Management Advisory Board  
Vice-Chairperson Royal Canadian Mounted Police Management Advisory Board  
Deputy Registrar Supreme Court of Canada  
Executive Director Telefilm Canada